The GIPR missense variant, rs1800437, has been associated with a large number of traits in the public domain, including BMI and body mass phenotypes, T2D, blood glucose and a number of metabolic or haematologic traits including blood pressure, reticulocyte and/or erythrocyte volume and urinary calculus (Supplementary Table 18)
Tirzepatide side effects (Phase 3 data) Nausea: 24-33% of participants (dose-dependent) Diarrhea: 18-23% Vomiting: 8-13% Constipation: 11-17% Discontinuation due to adverse events: 4.3-7.1% Serious adverse events: similar to placebo The difference in discontinuation rates is striking
2013 reported Phase 2 safety/tolerability of the AOD9604 modified form in obesity
Thus, early studies from Weninger et al
If pollen is dried upon heat (more than 40C to 50C), it affects the phenolic contents and pollen organoleptic features (191, 192)